There are 7 versions of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (8)

Popular Titles

Date-Rape Prevention Drug bill (Identified by CRS)

Short Titles

Short Titles as Enacted

Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000

Short Titles - House of Representatives

Short Titles as Passed House

Hillory J. Farias Date-Rape Prevention Drug Act of 1999

Short Titles as Reported to House

Hillory J. Farias Date-Rape Prevention Drug Act of 1999

Short Titles as Introduced

Hillory J. Farias Date-Rape Prevention Drug Act of 1999

Short Titles - Senate

Short Titles as Passed Senate

Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 1999

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Controlled Substances Act to add gamma hydroxybutyric acid and ketamine to the schedules of control substances, to provide for a national awareness campaign, and for other purposes.

Official Titles - Senate

Official Titles as Amended by Senate

An act to amend the Controlled Substances Act to direct the emergency scheduling of gamma hydroxybutyric acid, to provide for a national awareness campaign, and for other purposes.


Actions Overview (9)

Date Actions Overview
02/18/2000Became Public Law No: 106-172. (TXT | PDF)
02/18/2000Signed by President.
02/09/2000Presented to President.
01/31/2000Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendments Agreed to by the Yeas and Nays: (2/3 required): 339 - 2 (Roll no. 3).(consideration: CR H53-54; text: CR H55-57)
11/19/1999Passed/agreed to in Senate: Passed Senate in lieu of S. 1561 with an amendment and an amendment to the Title by Unanimous Consent.
10/12/1999Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 423 - 1 (Roll no. 493).(text: CR H9863-9864)
10/08/1999Committee on Judiciary discharged.
09/27/1999Reported (Amended) by the Committee on Commerce. H. Rept. 106-340, Part I.
06/10/1999Introduced in House

All Actions (36)

Date Chamber All Actions
02/18/2000Became Public Law No: 106-172. (TXT | PDF)
02/18/2000Signed by President.
02/09/2000HousePresented to President.
01/31/2000-6:33pmHouseMotion to reconsider laid on the table Agreed to without objection.
01/31/2000-6:33pmHouseOn motion that the House suspend the rules and agree to the Senate amendments Agreed to by the Yeas and Nays: (2/3 required): 339 - 2 (Roll no. 3). (consideration: CR H53-54; text: CR H55-57)
01/31/2000-2:34pmHouseAt the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 5, rule I, the chair announced that further proceedings on the motion would be postponed.
01/31/2000-2:17pmHouseDEBATE - The House proceeded with forty minutes of debate on the motion.
01/31/2000-2:16pmHouseMr. Upton moved that the House suspend the rules and agree to the Senate amendments.
11/22/1999SenateMessage on Senate action sent to the House.
11/19/1999SenatePassed Senate in lieu of S. 1561 with an amendment and an amendment to the Title by Unanimous Consent.
11/19/1999SenateSenate struck all after the Enacting Clause and substituted the language of S. 1561 amended.
11/19/1999SenateMeasure laid before Senate by unanimous consent. (consideration: CR S14872-14877)
10/13/1999SenateReceived in the Senate.
10/12/1999-8:00pmHouseThe title of the measure was amended. Agreed to without objection.
10/12/1999-8:00pmHouseMotion to reconsider laid on the table Agreed to without objection.
10/12/1999-8:00pmHouseOn motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 423 - 1 (Roll no. 493). (text: CR H9863-9864)
10/12/1999-7:52pmHouseConsidered as unfinished business. (consideration: CR H9876-9877)
10/12/1999-7:03pmHouseAt the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
10/12/1999-6:23pmHouseDEBATE - The House proceeded with forty minutes of debate on H.R. 2130.
10/12/1999-6:23pmHouseConsidered under suspension of the rules. (consideration: CR H9863-9872)
10/12/1999-6:23pmHouseMr. Upton moved to suspend the rules and pass the bill, as amended.
10/08/1999HousePlaced on the Union Calendar, Calendar No. 214.
10/08/1999HouseCommittee on Judiciary discharged.
09/27/1999HouseHouse Committee on Judiciary Granted an extension for further consideration ending not later than Oct. 8, 1999.
09/27/1999HouseReported (Amended) by the Committee on Commerce. H. Rept. 106-340, Part I.
08/05/1999HouseMs. Pryce (OH) asked unanimous consent that the Committee on Commerce have until midnight on Sept. 7 to file a report on H.R. 2130. Agreed to without objection.
08/05/1999HouseOrdered to be Reported (Amended) by Voice Vote.
Action By: Committee on Commerce
08/05/1999HouseCommittee Consideration and Mark-up Session Held.
Action By: Committee on Commerce
07/27/1999HouseForwarded by Subcommittee to Full Committee in the Nature of a Substitute by Voice Vote.
Action By: House Commerce Subcommittee on Health and Environment
07/27/1999HouseSubcommittee Consideration and Mark-up Session Held.
Action By: House Commerce Subcommittee on Health and Environment
06/24/1999HouseReferred to the Subcommittee on Health and Environment.
Action By: Committee on Commerce
06/18/1999HouseReferred to the Subcommittee on Crime.
Action By: Committee on the Judiciary
06/10/1999HouseReferred to House Judiciary
06/10/1999HouseReferred to House Commerce
06/10/1999HouseReferred to the Committee on Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
06/10/1999HouseIntroduced in House

Cosponsors (21)


Committees (2)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Commerce06/10/1999 Referred to
08/05/1999 Markup by
09/27/1999 Reported by H. Rept. 106-340
House Commerce Subcommittee on Health and Environment06/24/1999 Referred to
07/27/1999 Markup by
07/27/1999 Reported by
House Judiciary06/10/1999 Referred to
10/08/1999 Discharged from
House Judiciary Subcommittee on Crime06/18/1999 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Latest Summary (4)

There are 4 summaries for H.R.2130. View summaries

Shown Here:
Passed Senate amended (11/19/1999)

Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 1999 - Directs the Attorney General to issue, within 60 days, a final order that schedules gamma hydroxybutyric acid (GHB) (together with its salts, isomers, and salts of isomers) in the schedule under the Controlled Substances Act (CSA) relating to imminent hazards to public safety, with specified exceptions regarding: (1) manufacture, distribution, or possession of the drug in accordance with an exemption under the Federal Food, Drug, and Cosmetic Act (FFDCA) involving drugs for research; and (2) new drug products under the FFDCA. Deems GHB to be so scheduled if such final order is not issued within that period.

Amends the CSA and the Controlled Substances Import and Export Act to provide additional penalties relating to GHB.

Adds gamma butyrolactone (GBL) as an additional list I chemical.

(Sec. 4) Amends the CSA to authorize the Attorney General to establish specified reporting requirements for GHB products in Schedule III, including annual reports of end-of-year inventories and requirements that dispensing practitioners maintain certain records regarding prescriptions.

(Sec. 5) Specifies that the designation of GBL or any other chemical as a listed chemical under the CSA does not preclude a finding that the chemical is a controlled substance analogue. Includes controlled substance analogues within the scope of provisions regarding penalties for distribution of a controlled substance.

(Sec. 6) Directs the Attorney General to: (1) develop model protocols for the collection of toxicology specimens and the taking of victim statements in connection with investigations into and prosecutions related to possible violations of the CSA or other Federal or State laws that result in or contribute to rape, other crimes of violence, or other crimes involving abuse of GHB, and other controlled substances, or so-called "designer drugs," and develop model training materials for law enforcement personnel involved in such investigations; and (2) make such protocols and training materials available to Federal, State, and local personnel responsible for such investigations.

Directs the Attorney General to make a grant, in such amount and to such public or private person or entity as the Attorney General considers appropriate, for the development of forensic field tests to assist law enforcement officials in detecting the presence of GHB and related substances. Authorizes appropriations. Sets forth reporting requirements.

(Sec. 7) Directs the Secretary of Health and Human Services to submit to Congress annual reports each of which provides an estimate of the number of incidents of the abuse of date-rape drugs that occurred during the most recent one-year period for which data are available, with the first such report submitted by January 15, 2000.

Requires the Secretary to develop a plan for carrying out a national campaign to educate young adults, youths, law enforcement personnel, educators, school nurses, counselors of rape victims, and hospital emergency room personnel on: (1) the dangers of date-rape drugs; (2) the applicability of the CSA to such drugs, including penalties; (3) recognizing the symptoms that indicate an individual may be a victim of such drugs, including symptoms of sexual assault; and (4) appropriately responding when an individual has such symptoms.

Directs the Secretary to: (1) establish an advisory committee, composed of individuals who collectively possess expertise on the effects of, and detecting and controlling, date-rape drugs, to make recommendations regarding the plan; and (2) commence carrying out the national campaign within 180 days after its establishment. Requires the Comptroller General to submit to Congress, within two years, an evaluation of the effects with respect to date-rape drugs of the national campaign.

(Sec. 8) Directs the Attorney General, within 60 days after this Act's enactment, to establish within the Operations Division of the Drug Enforcement Administration a special unit which shall assess the abuse and trafficking in GHB, flunitrazepam, ketamine, other controlled substances, and other designer drugs whose use has been associated with sexual assault, including: (1) examining the threat posed by such substances and drugs on a national and on a regional basis; and (2) making recommendations regarding allocations and reallocations of resources to address the threat.

Directs the Attorney General, within 180 days, to submit to specified congressional committees a report setting forth the recommendations of the special unit, and specifying the allocations and reallocations of resources that the Attorney General proposes to make in response to the recommendations.